StockData
Vivos Therapeutics, Inc. logo

Vivos Therapeutics, Inc. (VVOS) stock

VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.08−0.00 (-3.04%)

Close on Nov 17, 2026Market cap $1.60MP/E –Yield –

Vivos Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Vivos Therapeutics's total debt was $8.14M at Jun 30, 2026. For fiscal 2025 it was $8.82M, up 635.2% from the year before. The highest annual figure on record is $8.82M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.82M+635.2%
FY2024Dec 31, 2024$1.20M0.0%
FY2023Dec 31, 2023$1.20M-5.1%
FY2021Dec 31, 2021$1.27M-1.9%
FY2020Dec 31, 2020$1.29M-65.2%
FY2019Dec 31, 2019$3.71M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.14M+2.8%
Q1 FY2026Mar 31, 2026$7.72M+543.1%
Q4 FY2025Dec 31, 2025$8.82M+635.2%
Q3 FY2025Sep 30, 2025$8.72M+626.5%
Q2 FY2025Jun 30, 2025$7.92M+559.8%
Q4 FY2024Dec 31, 2024$1.20M0.0%
Q3 FY2024Sep 30, 2024$1.20M0.0%
Q2 FY2024Jun 30, 2024$1.20M-5.1%
Q4 FY2023Dec 31, 2023$1.20M-5.1%
Q3 FY2023Sep 30, 2023$1.20M-5.1%
Q2 FY2023Jun 30, 2023$1.20M-5.1%
Q4 FY2021Dec 31, 2021$1.27M-1.9%
Q3 FY2021Sep 30, 2021$1.27M-65.9%
Q2 FY2021Jun 30, 2021$1.27M–
Q1 FY2021Mar 31, 2021$1.27M–
Q4 FY2020Dec 31, 2020$1.29M–
Q4 FY2019Dec 31, 2019$3.71M–

More Vivos Therapeutics figures

See a number that looks wrong?